GC Biopharma Market Cap

GC Biopharma has a market cap or net worth of 1.65 trillion as of March 9, 2026. Its market cap has increased by 4.27% in one year.

Market Cap

1.65T

Enterprise Value

2.79T

Revenue

1.93T

Ranking

n/a

PE Ratio

29.22

Stock Price

144,200.00

Market Cap Chart

Since August 29, 1995, GC Biopharma's market cap has increased from 29.09B to 1.65T, an increase of 5,558.37%. That is a compound annual growth rate of 14.12%.

Market Cap History

Date	Market Cap	% Change
Mar 9, 2026	1,645.78B	-9.31%
Dec 30, 2025	1,814.70B	-11.42%
Dec 30, 2024	2,048.67B	43.03%
Dec 28, 2023	1,432.35B	-3.09%
Dec 29, 2022	1,478.01B	-40.60%
Dec 30, 2021	2,488.07B	-46.31%
Dec 30, 2020	Pro	Pro
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 28, 2017	Pro	Pro
Dec 29, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Daewoong Pharmaceutical	1,953.76B
Chong Kun Dang Pharmaceutical	1,127.87B
Ildong Pharmaceutical	1,044.49B
Daewoong	965.02B
Celltrion Pharm	2,809.84B
Hanall Biopharma	2,813.20B
DongKook Pharmaceutical	887.62B
Boryung	800.03B

Market Cap Rankings